Jupiter Neurosciences, Inc. (JUNS)
JUNS Stock Price Chart
Explore Jupiter Neurosciences, Inc. interactive price chart. Choose custom timeframes to analyze JUNS price movements and trends.
JUNS Company Profile
Discover essential business fundamentals and corporate details for Jupiter Neurosciences, Inc. (JUNS) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
18 Jan 2022
Employees
4.00
Website
https://www.jupiterorphan.comCEO
Christer Rosen
Description
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.
JUNS Financial Timeline
Browse a chronological timeline of Jupiter Neurosciences, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 21 Aug 2025
Earnings released on 15 May 2025
EPS came in at -$0.05 falling short of the estimated -$0.03 by -66.67%.
Earnings released on 28 Mar 2025
EPS came in at -$0.05 falling short of the estimated -$0.02 by -150.00%.
Earnings released on 23 Dec 2024
EPS came in at -$0.02 .
Earnings released on 30 Jun 2024
EPS came in at $0.01 .
Earnings released on 31 Mar 2024
EPS came in at -$0.02 .
Earnings released on 31 Dec 2023
EPS came in at -$0.01 .
Earnings released on 30 Sept 2023
EPS came in at -$0.07 .
Earnings released on 30 Jun 2023
EPS came in at -$0.03 .
Earnings released on 31 Mar 2023
EPS came in at -$0.04 .
Earnings released on 30 Jun 2022
EPS came in at -$0.08 , while revenue for the quarter reached $233.28K .
Earnings released on 31 Mar 2022
EPS came in at -$0.07 .
Earnings released on 31 Dec 2021
EPS came in at -$0.23 .
Earnings released on 30 Sept 2021
EPS came in at -$0.14 .
Earnings released on 30 Jun 2021
EPS came in at -$0.09 , while revenue for the quarter reached $264.27K .
Earnings released on 31 Mar 2021
EPS came in at -$0.03 , while revenue for the quarter reached $373.77K .
Earnings released on 31 Dec 2020
EPS came in at -$0.05 , while revenue for the quarter reached $1.03M .
Earnings released on 30 Sept 2020
EPS came in at -$0.06 , while revenue for the quarter reached $101.00K .
JUNS Stock Performance
Access detailed JUNS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.